Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
Clinical trial NCT01411410 · COMPLETED
Trial details
- NCT number
- NCT01411410
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-24
- Primary completion
- 2014-10-22
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.